Following the Brexit vote, we helped a major pharmaceutical company develop new ideas for how the UK could prosper in life sciences.   Informed by a global listening exercise with senior leaders in the UK and overseas, we developed a position paper for the company which outlined ideas for change that could improve the global competitiveness of the UK. The multi-award winning work positioned our client as an expert on Brexit, reassured its employees that the company is committed to the UK and ambitious for its future, and stimulated a range of new Government policies to improve the operating environment and enable NHS patients to access new tests and treatments.